• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名慢性阻塞性肺疾病患者在使用异丙托溴铵治疗时出现应激性心肌病。

Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease.

作者信息

Melão Filipa, Nunes José P L, Vasconcelos Mariana, Dias Paula, Almeida Pedro B, Rodrigues Rui, Pinho Teresa, Madureira António, Maciel Maria J

机构信息

Serviço de Cardiologia, Centro Hospitalar São João, Porto, Portugal.

Serviço de Cardiologia, Centro Hospitalar São João, Porto, Portugal; Faculdade de Medicina da Universidade do Porto, Portugal.

出版信息

Rev Port Cardiol. 2014 Mar;33(3):175.e1-4. doi: 10.1016/j.repc.2013.10.012. Epub 2014 Mar 27.

DOI:10.1016/j.repc.2013.10.012
PMID:24680554
Abstract

Stress-induced cardiomyopathy, also known as 'broken heart syndrome' or Takotsubo cardiomyopathy, is characterized by transient systolic dysfunction of the apical and/or mid segments of the left ventricle, in the absence of significant coronary artery disease. We report the case of a 56-year-old male patient with chronic obstructive pulmonary disease (COPD), with stress-induced cardiomyopathy associated with the use of ipratropium bromide, administered in the context of an acute exacerbation of COPD.

摘要

应激性心肌病,也被称为“心碎综合征”或Takotsubo心肌病,其特征是左心室心尖和/或中间段出现短暂性收缩功能障碍,而不存在明显的冠状动脉疾病。我们报告了一例56岁男性慢性阻塞性肺疾病(COPD)患者的病例,该患者在COPD急性加重期使用异丙托溴铵后出现了应激性心肌病。

相似文献

1
Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease.一名慢性阻塞性肺疾病患者在使用异丙托溴铵治疗时出现应激性心肌病。
Rev Port Cardiol. 2014 Mar;33(3):175.e1-4. doi: 10.1016/j.repc.2013.10.012. Epub 2014 Mar 27.
2
Takotsubo cardiomyopathy and chronic obstructive pulmonary disease.
Rev Port Cardiol. 2014 Oct;33(10):659. doi: 10.1016/j.repc.2014.04.003. Epub 2014 Oct 13.
3
Takotsubo cardiomyopathy and chronic obstructive pulmonary disease--reply.
Rev Port Cardiol. 2014 Oct;33(10):661-2. doi: 10.1016/j.repc.2014.09.004. Epub 2014 Oct 16.
4
Chronic obstructive pulmonary disease and hypertrophic obstructive cardiomyopathy: two antagonistic obstructions.慢性阻塞性肺疾病与肥厚性梗阻性心肌病:两种对抗性梗阻。
Int J Cardiol. 2014 Oct 20;176(3):e129-30. doi: 10.1016/j.ijcard.2014.07.215. Epub 2014 Aug 4.
5
Comparison of the efficacy of aerosol inhalation between the ipratropium bromide and terbutaline on the patients with AECOPD.异丙托溴铵与特布他林雾化吸入对慢性阻塞性肺疾病急性加重期患者疗效的比较。
Pak J Pharm Sci. 2019 Sep;32(5(Special)):2489-2493.
6
Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease.吸入用沙丁胺醇/硫酸沙丁胺醇和异丙托溴铵及其联合制剂治疗慢性阻塞性肺疾病。
Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):381-92. doi: 10.1517/17425251003649549.
7
Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.异丙托溴铵干粉剂与定量吸入器制剂一样安全有效:慢性阻塞性肺疾病患者的累积剂量-反应研究
Respir Care. 2002 Feb;47(2):159-66.
8
Tiotropium: a potential replacement for ipratropium in patients with COPD.噻托溴铵:慢性阻塞性肺疾病患者中异丙托溴铵的潜在替代药物。
Issues Emerg Health Technol. 2002 Jul(35):1-4.
9
Anticholinergic agents in asthma and COPD.哮喘和慢性阻塞性肺疾病中的抗胆碱能药物。
Eur J Pharmacol. 2006 Mar 8;533(1-3):36-9. doi: 10.1016/j.ejphar.2005.12.072. Epub 2006 Feb 20.
10
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.吸入用丙酸氟替卡松/沙美特罗与异丙托溴铵/沙丁胺醇治疗慢性阻塞性肺疾病的疗效和安全性:一项为期8周的多中心、随机、双盲、双模拟、平行组研究。
Clin Ther. 2005 May;27(5):531-42. doi: 10.1016/j.clinthera.2005.05.009.

引用本文的文献

1
Pharmacological Triggers of Takotsubo Cardiomyopathy: An Updated Review of Evidence and Recommendations.药理学触发的心肌顿抑症:证据更新及建议综述。
Curr Cardiol Rev. 2024;20(2):50-60. doi: 10.2174/011573403X273613240125072754.
2
Frequently Recurrent Takotsubo Syndrome in COPD.慢性阻塞性肺疾病中频繁复发的应激性心肌病
Case Rep Cardiol. 2019 Jan 9;2019:6706935. doi: 10.1155/2019/6706935. eCollection 2019.
3
Recurrent Stress Cardiomyopathy During COPD Exacerbation: Are Beta-adrenergic Agonists Only to Blame?慢性阻塞性肺疾病急性加重期复发性应激性心肌病:仅归咎于β-肾上腺素能激动剂吗?
Cureus. 2017 Apr 14;9(4):e1166. doi: 10.7759/cureus.1166.